Saudi Arabia Oral Solid Dosage Cdmo Market Size & Outlook
Related Markets
Saudi Arabia oral solid dosage cdmo market highlights
- The Saudi Arabia oral solid dosage cdmo market generated a revenue of USD 254.4 million in 2024 and is expected to reach USD 389.9 million by 2033.
- The Saudi Arabia market is expected to grow at a CAGR of 4.8% from 2025 to 2033.
- In terms of segment, tablets was the largest revenue generating product in 2024.
- Capsules is the most lucrative product segment registering the fastest growth during the forecast period.
Oral solid dosage cdmo market data book summary
| Market revenue in 2024 | USD 254.4 million |
| Market revenue in 2033 | USD 389.9 million |
| Growth rate | 4.8% (CAGR from 2025 to 2033) |
| Largest segment | Tablets |
| Fastest growing segment | Capsules |
| Historical data | 2021 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Tablets, Capsules, Powders, Granules, Others Product |
| Key market players worldwide | Catalent Inc, Lonza Group Ltd, Kuehne + Nagel International AG, Boehringer Ingelheim, Thermo Fisher Scientific Inc, Siegfried Holding AG, AbbVie Inc, Chemical Works of Gedeon Richter PLC, Jubilant Pharmova, Piramal Pharma Solutions, Recipharm, CordenPharma, Alcami, DPT Laboratories, SPI Pharma, Quotient Sciences, Rubicon Research, Almac Group, Aenova Group |
Other key industry trends
- In terms of revenue, Saudi Arabia accounted for 0.6% of the global oral solid dosage cdmo market in 2024.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
- In Middle East & Africa, South Africa oral solid dosage cdmo market is projected to lead the regional market in terms of revenue in 2033.
- UAE is the fastest growing regional market in Middle East & Africa and is projected to reach USD 387.6 million by 2033.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Oral Solid Dosage CDMO Market Scope
Oral Solid Dosage CDMO Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Rubicon Research | View profile | 251-500 | Mumbai, Maharashtra, India, Asia | http://www.rubicon.co.in/ |
| SPI Pharma | View profile | 251-500 | Wilmington, Delaware, United States, North America | http://spipharma.com |
| Aenova Group | View profile | 5001-10000 | Greensboro, North Carolina, United States, North America | http://www.aenova-group.com |
| Quotient Sciences | View profile | 251-500 | Nottingham, Nottingham, United Kingdom, Europe | https://www.quotientsciences.com/ |
| Jubilant Pharmova | View profile | 10001+ | Noida, Uttar Pradesh, India, Asia | https://www.jubilantpharmova.com |
| DPT Laboratories | View profile | 1001-5000 | San Antonio, Texas, United States, North America | https://www.dptlabs.com |
| Almac Group | View profile | 1001-5000 | Craigavon, Craigavon, United Kingdom, Europe | https://www.almacgroup.com |
| CordenPharma | View profile | 5001-10000 | Plankstadt, Baden-Wurttemberg, Germany, Europe | http://cordenpharma.com |
| Alcami | View profile | 501-1000 | Wilmington, North Carolina, United States, North America | http://www.alcaminow.com |
| Piramal Pharma Solutions | View profile | 1001-5000 | Riverview, Michigan, United States, North America | http://www.piramalpharmasolutions.com/ |
| Recipharm | View profile | 1001-5000 | Jordbro, Stockholms Lan, Sweden, Europe | http://www.recipharm.com |
| Chemical Works of Gedeon Richter PLC | View profile | 11901 | Gyomroi ut 19-21, Budapest, Hungary, 1103 | https://www.gedeonrichter.com/hu-hu |
| Siegfried Holding AG | View profile | 4180 | Untere Bruehlstrasse 4, Zofingen, Switzerland, CH-4800 | https://www.siegfried.ch |
| Catalent Inc | View profile | 17219 | 14 Schoolhouse Road, Somerset, NJ, United States, 08873 | https://www.catalent.com |
| Kuehne + Nagel International AG | View profile | 93064 | Dorfstrasse 50, P.O. Box 67, Schindellegi, Switzerland, CH-8834 | http://www.kuehne-nagel.com |
| Boehringer Ingelheim | View profile | 10001+ | Ingelheim Am Rhein, Rheinland-Pfalz, Germany, Europe | https://www.boehringer-ingelheim.com/ |
| Thermo Fisher Scientific Inc | View profile | 122000 | 168 Third Avenue, Waltham, MA, United States, 02451 | https://www.thermofisher.com |
| Lonza Group Ltd | View profile | 18000 | Muenchensteinerstrasse 38, Basel, Switzerland, CH-4002 | https://www.lonza.com |
| AbbVie Inc | View profile | 50000 | 1 North Waukegan Road, North Chicago, IL, United States, 60064-6400 | http://www.abbvieinvestor.com |
Saudi Arabia oral solid dosage cdmo market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to oral solid dosage cdmo market will help companies and investors design strategic landscapes.
Tablets was the largest segment with a revenue share of 36.36% in 2024. Horizon Databook has segmented the Saudi Arabia oral solid dosage cdmo market based on tablets, capsules, powders, granules, others product covering the revenue growth of each sub-segment from 2021 to 2033.
Saudi Arabia held a 21.96% share of the MEA market in 2023 and is poised for significant growth over the forecast period. Key factors expected to boost the country’s market include the increasing adoption of biological therapies, growing awareness of the benefits of oral solid dosage products.
With a growing prevalence of diseases, the presence of CMOs/CDMOs, and a surge in clinical trials, the pharmaceutical industry in Saudi Arabia is expected to reap substantial benefits in the coming years.
Furthermore, the country’s embrace of generic drugs is contributing to the expansion of the oral solid dosage CDMO market. For instance, the launch of Lifera by the Public Investment Fund in June 2023 underscores the country’s commitment to fostering the growth of the local pharmaceutical industry.
Reasons to subscribe to Saudi Arabia oral solid dosage cdmo market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Saudi Arabia oral solid dosage cdmo market databook
-
Our clientele includes a mix of oral solid dosage cdmo market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Saudi Arabia oral solid dosage cdmo market , including forecasts for subscribers. This country databook contains high-level insights into Saudi Arabia oral solid dosage cdmo market from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Partial client list
Saudi Arabia oral solid dosage cdmo market size, by product, 2021-2033 (US$M)
Saudi Arabia Oral Solid Dosage CDMO Market Outlook Share, 2024 & 2033 (US$M)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
